Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Osteopore Ltd. ( (AU:OSX) ) is now available.
Osteopore Ltd. has received Research Governance Office clearance for a clinical study at Princess Alexandra Hospital, focusing on jawbone regeneration using its advanced PCL-TCP scaffold technology. This study aims to address the challenges of current treatments by exploring a regenerative approach that could improve patient outcomes globally, with the first patient recruitment expected in four weeks.
More about Osteopore Ltd.
Osteopore Ltd. is a global medical technology company founded in Singapore and listed in Australia. It commercializes products designed to enable natural bone healing across multiple therapeutic areas. The company uses patented technology to fabricate micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material, which dissolve over time to allow natural bone tissue growth, reducing complications associated with permanent implants.
Average Trading Volume: 2,213,746
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$2.69M
For detailed information about OSX stock, go to TipRanks’ Stock Analysis page.